Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 +0.03 (+7.87%)
As of: Oct 23, 2026 · 1:39 PM EDT

Citius Pharmaceuticals (CTXR) Price to Sales (2014 - 2026)

Updated

Citius Pharmaceuticals' (CTXR) Price to Sales came in at 2.36 for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 34.3% from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Price to Sales (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.17 Bn 1,101.76 Bn 19.71 Bn
2 Johnson & Johnson 634.79 Bn 554.65 Bn 17.30 Bn
3 AbbVie 506.40 Bn 479.51 Bn 12.70 Bn
4 Merck 357.93 Bn 312.31 Bn 12.21 Bn
5 Novartis Ag 292.69 Bn 256.68 Bn 11.24 Bn
6 Astrazeneca 265.19 Bn 238.87 Bn 12.86 Bn
7 Amgen 238.22 Bn 193.61 Bn 7.24 Bn
8 Gilead Sciences 195.23 Bn 169.43 Bn 6.22 Bn
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn
10 Citius Pharmaceuticals 10.47 Mn -23.10 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.36
Mar 31, 2026 3.59
Dec 31, 2025 4.42
Sep 30, 2016 1.06 Mn
Jun 30, 2016 1.78 Mn
Mar 31, 2016 5.43 Mn
Dec 31, 2015 1.84 Mn
Sep 30, 2015 472,955.76
Jun 30, 2015 492,285.50
Mar 31, 2015 535,295.34
Dec 31, 2014 366,006.52
API Access

Citius Pharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CTXR&period=max&api_key=YOUR_API_KEY